tepotinib
merck
['lung', 'tepotinib']
a clinical trial led by dr. xiuning le shows promising results for tepotinib with an egfr tyrosine kinase inhibitor in patients with egfr mutant met-altered non-small cell lung cancer (9070). #asco23 #lungcancer #endcancer 4/4 
MD Anderson is a global leader in cancer care, research, education and training, and prevention. Appointments available: 1-877-632-6789